EMILY CLARK: Open Payments
NPI 1942448147 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,135 in 98 payments from 13 companies in 2025. Trend: 2023 $855 · 2024 $1,654 · 2025 $3,135
Food & beverage: $1,959Travel & lodging: $1,080Education: $95
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $1,810 |
| ABBVIE INC. | 31 | $469 |
| Janssen Biotech, Inc. | 18 | $308 |
| Galderma Laboratories, L.P. | 20 | $272 |
| Lilly USA, LLC | 3 | $54 |
| UCB, Inc. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| LEO Pharma Inc. | 1 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Organon LLC | 1 | $22 |
Products named: TREMFYA, RINVOQ, NEMLUVIO, COSENTYX, SKYRIZI, EBGLYSS, Bimzelx, DUPIXENT.
Industry payments across PA — which companies pay providers there.
